Updated · 1 episodes · 1 show · 1 source notes
Teo Soleymani
Overview
Teo Soleymani is the dermatologist and dermatologic surgeon interviewed by Andrew Huberman in a Huberman Lab episode on skin health, appearance, inflammatory disease, ultraviolet exposure, skin cancer, and evidence-based treatment.
Current Profile
The source presents Soleymani as a clinician who joins cosmetic goals to barrier biology and cancer surveillance. He favors simple, tolerable daily care and physical sun protection, then reserves prescription retinoids, immune-directed treatment, and procedural tools for appropriate indications and supervision. His account resists two extremes: expensive product complexity is not evidence of effectiveness, and ultraviolet exposure is neither harmless nor a complete explanation of every skin cancer.
Key Characteristics
- Explains visible skin through renewal, barrier function, blood flow, connective tissue, inflammation, immune activity, and environmental exposure.
- Prioritizes low-complexity cleansing and moisturizing over price, fragrance, or long ingredient lists.
- Uses a dose-and-context model for sunlight that emphasizes avoiding burns and combining physical barriers with sunscreen.
- Distinguishes weak cosmetic actives from prescription retinoids and clinician-selected procedures with meaningful effects and risks.
- Treats skin-cancer risk as multifactorial, joining ultraviolet damage to genetics, immune surveillance, HPV, lesion location, and family history.
- Separates broad education from individualized diagnosis, prescribing, procedures, and cancer surveillance.
Evidence
- Barrier-first care: How to Improve & Protect Your Skin Health & Appearance | Dr. Teo Soleymani has Soleymani favor mild fragrance-free cleansers, skin-type-matched moisturizers, and avoidance of over-cleansing.
- Exposure judgment: How to Improve & Protect Your Skin Health & Appearance | Dr. Teo Soleymani combines limited sunlight, burn avoidance, physical barriers, and broad-spectrum mineral sunscreen preference.
- Treatment hierarchy: How to Improve & Protect Your Skin Health & Appearance | Dr. Teo Soleymani distinguishes prescription retinoids and laser resurfacing from weaker over-the-counter actives and variable red-light devices.
- Disease mechanisms: How to Improve & Protect Your Skin Health & Appearance | Dr. Teo Soleymani explains psoriasis, vitiligo, acne, rosacea, and eczema through different barrier, immune, vascular, microbial, and genetic mechanisms.
- Cancer surveillance: How to Improve & Protect Your Skin Health & Appearance | Dr. Teo Soleymani links full-body examination and family history to UV damage, HPV, immune recognition, and cancers outside routinely sun-exposed skin.
Qualifications
This profile is bounded to one episode note and is not an independent biography, credential check, publication review, or assessment of Soleymani’s clinical practice. The source introduces him as double board certified, Stanford-trained, and formerly on UCLA’s clinical faculty, but those details are not independently verified here. Its medical, product, supplement, procedural, screening, vaccination, and cancer-treatment statements are public education rather than individualized dermatology or oncology advice.
What Changed
- Created the page from the Huberman Lab skin-health interview.
- Established Soleymani’s barrier-first routine, calibrated sun-protection stance, treatment hierarchy, and multifactorial skin-cancer frame.
Relationships
- Huberman Lab - podcast setting for Soleymani’s dermatology discussion.
- Andrew Huberman - host who elicits mechanism, product, treatment, and cancer-risk distinctions.
- Skin Barrier Routine - daily-care framework grounded by Soleymani’s cleansing and moisturizing guidance.
- UV Exposure and Skin Protection - exposure and protection framework shaped by his dose-and-context account.
- Dermatologic Renewal and Cancer Prevention - clinical intervention and surveillance branch developed in the interview.
- Protein Source Goal Matching - nutrition boundary qualified by his uncertainty about collagen-specific effects.